Lv62
2390 积分 2024-08-13 加入
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
6天前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
6天前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
7天前
已完结
Large‐scale propagation of a replication‐defective adenovirus vector in stirred‐tank bioreactor PER.C6™ cell culture under sparging conditions
14天前
已完结
Serum‐free suspension cultivation of PER.C6® cells and recombinant adenovirus production under different pH conditions
14天前
已完结
Design of transgenes for efficient expression of active chimeric proteins on mammalian cells
14天前
已完结
Fed‐batch cultivation of animal cells using different medium design concepts and feeding strategies
14天前
已完结
Population Pharmacokinetics of SCT510 (a Bevacizumab Biosimilar) and Avastin® in Healthy Subjects and Patients with Non-squamous Non-small Cell Lung Cancer
14天前
已完结
Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin®) in Patients with Non-squamous Non-small Cell Lung Cancer
14天前
已完结
An anti-PD-1 antibody (SCT-I10A) plus anti-EGFR antibody (SCT200) and chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer: A phase Ib study
1个月前
已完结
皖公网安备34019202002308
